ADHD

Screening for the symptom of worthlessness could save your adolescent patient’s life…

The experts weighed in on a wide variety of psychiatric issues for the November 2022 issue of Psychiatric Times.

Experts in attention-deficit/hyperactivity disorder discuss future nonmedication interventions, like trigeminal nerve stimulation and digital therapeutics.

Theresa Cerulli, MD, discusses the practical considerations for using serdexmethylphenidate-dexmethylphenidate for the treatment of attention-deficit/hyperactivity disorder.

What are the advances in adult ADHD?

Theresa Cerulli, MD, describes the indication and mechanism of the recent FDA approved combination product serdexmethylphenidate /dexmethylphenidate for the treatment of attention deficit/hyperactivity disorder (ADHD).

Experts in attention-deficit/hyperactivity disorder (ADHD) discuss how to determine treatment failure in adults and the benefit of different dosing strategies for therapeutic options.

ADHD is an all-day affair, and treating it in an adult population can be difficult.

Theresa Cerulli, MD, and Anthony Rostain, MD, MA, discuss challenges with substance abuse related to pharmacologic interventions for adult attention-deficit/hyperactivity disorder (ADHD) treatment.

Experts in treatment of attention-deficit/hyperactivity disorder discuss the benefits of different drug formulations and the potential for abuse of immediate-release medications.

Anthony Rostain, MD, MA, provides an overview of stimulants, nonstimulants, amphetamines, and methylphenidates for adult attention-deficit/hyperactivity disorder (ADHD) treatment.

Experts in attention-deficit/hyperactivity disorder (ADHD) discuss the importance of patient education and shared decision-making in working toward treatment goals.

From complementary and alternative approaches in the COVID-19 era to mental health’s most toxic myth, here are highlights from the week in Psychiatric Times.

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss novel drug delivery systems and provide take-home messages when treating an adult with ADHD.

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss implications of pharmacogenetic testing in ADHD.

There are no treatment guidelines for ADHD in adults in the United States, but you can still tackle this challenging diagnosis.

Why are more and more adult women being diagnosed with ADHD? A presentation at the APNA Annual Conference shed light on the issue.

From traumatic brain injury to the dangers of excessive social media usage, here are highlights from the week in Psychiatric Times.

Recent research determined the medications modafinil, atomoxetine, and guanfacine negatively impact bones.

Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?

A panel of ADHD specialists discuss the impact of treatment delay when dealing with an adult patient.

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to co-manage a patient with ADHD with other specialties.

Experts in psychiatry discuss tips to differentiate between ADHD and other co-morbid psychiatric disorders.

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss factors which prompt adults for an ADHD consultation.

Stephen Faraone, PhD, presents the case of a 19-year-old male with ADHD.